Working up autism: The practical role of medical genetics

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 160 C, Issue 2, 2012, Pages 104-110

  Gurrieri, Fiorella ^a,b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autism spectrum disorders; CGH microarray; Genetic counseling; Molecular tests; Physical examination

Indexed keywords

ARTICLE; AUTISM; CHROMOSOME DISORDER; CLINICAL EVALUATION; CLINICAL FEATURE; COPY NUMBER VARIATION; CREATINE BIOSYNTHESIS AND TRANSPORT DISORDER; DUCHENNE MUSCULAR DYSTROPHY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FRAGILE X SYNDROME; GENE LOCUS; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; MEDICAL GENETICS; MOEBIUS SYNDROME; MOLECULAR DIAGNOSIS; PHELAN MCDERMID SYNDROME; PHENYLKETONURIA; PRIORITY JOURNAL; PTEN EXTREME MACROCEPHALY SYNDROME; RECURRENCE RISK; RETT SYNDROME; SEX DIFFERENCE; SMITH LEMLI OPITZ SYNDROME; SOTOS SYNDROME; SYNDROME; TIMOTHY SYNDROME; TUBEROUS SCLEROSIS;

AUTISTIC DISORDER; CHILD; GENETIC COUNSELING; GENETIC TESTING; GENETICS, MEDICAL; HUMANS; PHENOTYPE; PROGNOSIS;

EID: 84859990409     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.31326     Document Type: Article

References (51)

1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators, Centers for Disease Control and Prevention. 2007. Prevalence of autism spectrum disorders-Autism and developmental disabilities monitoring network, six sites, United States, 2000. MMWR Surveill Summ 56: 1- 11.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association.
3. Baieli S, Pavone L, Meli C, Fiumara A, Coleman M. 2003. Autism and phenylketonuria. J Autism Dev Disord 33: 201- 204.
4. Baker P, Piven J, Sato Y. 1998. Autism and tuberous sclerosis complex: Prevalence and clinical features J Aut Dev Disord 28: 279- 285.
5. Baron-Cohen S. 2006. The hyper-systemizing, assortative mating theory of autism. Prog Neuro-Psychopharmacol Biol Psychiatry 30: 865- 872.
6. Bayley A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. 1995. Autism as a strong genetic disorder: Evidence from a British twin study. Psychol Med 25: 63- 77.
7. Bayley A. 2011. Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42- 77.
8. Buchen L. 2011. When geeks meet. Nature 479: 25- 27.
9. Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. 2007. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet Part B 144B: 484- 491.
10. Chakrabarti S, Fombonne E. 2005. Pervasive developmental disorders in preschool children: Confirmation of high prevalence. Am J Psychiatry 162: 1133- 1141.
11. Creswell C, Skuse D. 1999. Autism in association with Turner syndrome: Genetic implications for male vulnerability to pervasive developmental disorders. Neurocase 5: 101- 108.
12. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, Schultz RT, Crawley J, Young LJ. 2006. The developmental neurobiology of autism spectrum disorder. J Neurosci 26: 6897- 6906.
13. Duchan E, Patel DR. 2012. Epidemiology of autism spectrum disorders. Pediatr Clin North Am 59: 27- 43.
14. Dykens EM, Sutcliffe JS, Levitt P. 2004. Autism and 15q11-q13 disorders: Behavioral, genetic, and pathophysiological issues. Ment Retard Dev Disabil Res Rev 10: 284- 291.
15. Eliasen M, Tolstrup JS, Nybo Andersen AM, Grønbaek M, Olsen J, Strandberg-Larsen K. 2010. Prenatal alcohol exposure and autistic spectrum disorders. A population-based prospective study of 80, 552 children and their mothers. Int J Epidemiol 39: 1074- 1081.
16. Fombonne E. 1999. The epidemiology of autism: A review. Psychol Med 29: 769- 786.
17. Grafodatskaya D, Chung B, Szatmari P, Weksberg R. 2010. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 49: 794- 809.
18. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, Lintas C, Abramson RK, Wright HH, Ellis P, Langford CF, Worley G, Delong GR, Murphy SK, Cuccaro ML, Persico A, Pericak-Vance MA. 2009. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. BMC Med 7: 62.
19. Gurrieri F, Neri G. 2009. Defective oxytocin function: A clue to understanding the cause of autism? BMC Med 7: 62.
20. Harrington JW, Patrick PA, Brand DA. 2006. Parental beliefs about autism: Implications for the treating physician. Autism 10: 452- 462.
21. Hass RH. 2010. Autism and mitochondrial disease. Dev Disabil Res Rew 16: 144- 153.
22. Herbert MR. 2010. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders. Curr Opin Neurol 23: 103- 110.
23. Herbert MR. 2011. SHANK3, the synapse and autism. N Engl J Med 365: 173- 175.
24. Howlin P, Goode S, Hutton J, Rutter M. 2004. Adult outcome for children with autism. J Child Psychol Psychiatry 45: 212- 229.
25. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. 2011. Advancing paternal age and risk of autism: New evidence from a population-based study and a meta-analysis of epidemiological studies. Mol Psychiatry 16: 1203- 1212.
26. Jeste SS, Sahin M, Bolton P, Ploubidis GB, Humphrey A. 2008. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol 23: 520- 525.
27. Johnson CP, Myers SM, American Academy of Pediatrics Council on Children With Disabilities. 2007. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120: 1183- 1215.
28. Kent L, Evans J, Sharp M. 1999. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol 41: 153- 158.
29. Miles JH. 2011. Autism spectrum disorders-A genetics review. Genet Med 13: 278- 294.
30. Miles JH, Takahashi TN, Haber A, Hadden L. 2003. Autism families with a high incidence of alcoholism. J Autism Dev Disord 33: 403- 415.
31. Miles JH, Takahashi TN, Bagby S, Sahota PK, Vaslow DF, Wang CH, Hillman RE, Farmer JE. 2005. Essential versus complex autism: Definition of fundamental prognostic subtypes. Am J Med Genet Part A 135A: 171- 180.
32. Mottron L. 2011. Changing perceptions: The power of autism. Nature 479: 33- 35.
33. Newmeyer A, de Grauw T, Clark J, Chuck G, Salomons G. 2007. Screening of male patients with autism spectrum disorder for creatine transporter deficiency. Neuropediatrics 38: 310- 312.
34. Olivié H. 2012. Clinical practice: The medical care of children with autism. Eur J Pediatr DOI: 10.1007/s00431-011-1669-1.
35. O' Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, Karakoc E, Mackenzie AP, Ng SB, Baker C, Rieder MJ, Nickerson DA, Bernier R, Fisher SE, Shendure J, Eichler EE. 2011. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43: 585- 589.
36. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L, Bryson S, Carver LJ, Constantino JN, Dobkins K, Hutman T, Iverson JM, Landa R, Rogers SJ, Sigman M, Stone WL. 2011. Recurrence risk for autism spectrum disorders: A baby siblings research consortium study. Pediatrics 128: 488- 495.
37. Palac S, Meador KJ. 2011. Antiepileptic drugs and neurodevelopment: An update. Curr Neurol Neurosci Rep 11: 423- 427. Review.
38. Reddy KS. 2005. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder. BMC Med Genet 6: 3.
39. Roesser J. 2011. Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clin Pediatr 50: 834- 843.
40. Schaaf CP, Sabo A, Sakai Y, Crosby J, Muzny D, Hawes A, Lewis L, Akbar H, Varghese R, Boerwinkle E, Gibbs RA, Zoghbi HY. 2011. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet 20: 3366- 3375.
41. Schaefer GB, Mendelsohn NJ. 2008. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med 10: 301- 305.
42. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimäki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M. 2007. Strong association of de novo copy number mutations with autism. Science 316: 445- 449.
43. Selkirk CG, McCarthy Veach P, Lian F, Schimmenti L, LeRoy BS. 2009. Parents' perceptions of autism spectrum disorder etiology and recurrence risk and effects of their perceptions on family planning: Recommendations for genetic counselors. J Genet Couns 18: 507- 519.
44. Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, Miller KJ, Frazier JA, Silverstein I, Picker J, Weissman L, Raffalli P, Jeste S, Demmer LA, Peters HK, Brewster SJ, Kowalczyk SJ, Rosen-Sheidley B, McGowan C, Duda AW III, Lincoln SA, Lowe KR, Schonwald A, Robbins M, Hisama F, Wolff R, Becker R, Nasir R, Urion DK, Milunsky JM, Rappaport L, Gusella JF, Walsh CA, Wu BL, Miller DT, Autism Consortium Clinical Genetics/DNA Diagnostics Collaboration. 2010. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125: 727- 735.
45. Sikora DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD. 2006. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet Part A 140A: 1511- 1518.
46. Tuchman R, Rapin L. 2002. Epilepsy in autism. Lancet Neurol 1: 352- 358.
47. Van den Berghe G, Vincent MF, Jaeken J. 1997. Inborn errors of the purine nucleotide cycle: Adenylosuccinase deficiency. J Inherit Metab Dis 20: 193- 202.
48. Varga EA, Pastore M, Prior T, Herman GE, McBride KL. 2009. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 11: 111- 117.
49. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, Cantor RM, Blencowe BJ, Geschwind DH. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380- 384.
50. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ, Autism Consortium. 2008. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358: 667- 675.
51. Zachor DA, Ben Itzchak E. 2011. Assisted reproductive technology and risk for autism spectrum disorder. Res Dev Disabil 32: 2950- 2956.